Today I'd like to look at the taxes on providers, including health insurance companies ($60 billion by 2019), pharmaceuticals ($27 billion) and medical device manufacturers ($20 billion). These organizations pay about 20% of all the taxes raised by Obamacare. Yet, most of these companies supported passage. Why would they do that?
These companies will see a huge surge in demand as a result of Obamacare. More people with insurance means more customers for insurance companies, as well as more people able to afford pharmaceuticals and medical devices. Should the companies be allowed to keep the entirety of the windfall resulting from Obamacare (and not from their own initiative or invention), or should they pay a portion of the added profits in taxes? Even with the added taxes, these companies will benefit as a result of Obamacare. They earn lots more in income, and part of that income goes to pay for the programs that led to their getting more income. And there's the not-insignificant benefit that more American citizens will be able to have the drugs and devices they need to be healthy and productive. It's a win all the way around.
No comments:
Post a Comment